RENNES, FRANCE — March, 29 2019 — DIAFIR, a medical technology company focused on the development, manufacture and sale of innovative diagnostic solutions in nonalcoholic steatohepatitis (NASH) and septic arthritis announces today the appointment of Mr Richard Guillaume to its Board of Directors
Mr Guillaume has a wide experience of over 30 years in international management and operations in the pharmaceutical industry as well as in the medtech. Drawing on his experience and knowledge in the field of medical devices and diagnosis, Mr Guillaume will advise and help the Company in its development.
Alongside his role at Diafir, Richard Guillaume has been the General Manager of Echosens from 2008 until 2013. He was previously Executive Vice President Global Sales and Marketing at Blatchford, a UK medical device company. He was also member of the board. Prior, he held various positions such as Director Global Marketing of Abbott International in Chicago and Director Category Development Europe of Mead Johnson. Richard holds a Master in Business Administration from Poitiers University and a DESS in Marketing from Paris Dauphine completed by a general management program at INSEAD.
Hugues Tariel, Founder and CEO of DIAFIR, said: “We are delighted to welcome Richard as a Diafir board member. His vision and experience will be a great addition to our team, to ensure SPIDTM platform success for NASH in hepatology and more broadly as an accurate, fast and versatile diagnostic tool.” Richard Guillaume, declared: “I’m pleased to join the board of Diafir who is developing a new innovative in vitro diagnostic technology to improve patient quality of life».
DIAFIR will be in Vienna from April 10-14, 2019 for the annual EASL International Liver Disease Conference.
EASL (European Association for the Study of the Liver) is a medical association dedicated to the pursuit of excellence in the field of liver research, the clinical practice of liver disorders and training.
Its goal is to spread knowledge and expertise on best practices and the latest scientific breakthroughs in hepatology.
Congress web Site
This year Diafir will still travel a lot. Our next dates of congress and participation in scientific events.
- 10-14 Avril 2019 : EASL, Vienne, Autriche
- 14-16 Mai 2019 : MedTech Europe, Paris, France
- 5-7 Juin 2019 : National Infectiology Day, Lyon, France
- 12-15 Juin 2019 : EULAR, Madrid, Espagne
- 11-12 Juillet 2019 : NASH Symposium, Paris, France
- 8-12 Novembre 2019 : AASLD, Boston, USA
- 21-22 Novembre 2019 :Innovation Day in Biology,, Paris, France
- 8-10 Décembre 2019 : Congress French Society of Rheumatology, Paris, France
These events are opportunities to meet, do not hesitate to contact us before. Contact form
The fourth event of the Photonic Roadshow was held in Marseille on November 17th. It is an understatement that the meetings
were rich. Experts from all countries covered a wide range of topics ranging from medical market trends and needs to photonic technologies, to the transformation of regulatory requirements into value added for products.
We presented the DIAFIR journey and developed the topic of health by focusing on the essential aspect of the regulatory qualification of a photonic equipment for the medical.
Thank you again for your enthusiasm.
(thanks to Laëtitia Clavé from the OPTITEC Pole for the photo)
DIAFIR will be present from 3 to 6 October in Lyon at the scientific days of the AFEF (French Society for the Study of the Liver).
Continue reading “Scientific days of the AFEF, 3 to 6 October in Lyon”